Nancy Simonian

Nancy Simonian is the chief executive officer of Syros Pharmaceuticals, a life sciences company focused on treating diseases by mapping gene regulatory circuits. She also serves as the board director of Seattle Genetics. Previously, she held the same position at Damon Runyon Cancer Research Foundation.

Before joining Damon Runyon Cancer Research Foundation, Simonian provided her services as the chief medical officer of Millennium Pharmaceuticals. Prior to that, she was the vice president for clinical development at Biogen. She began her career as a member of the faculty at Harvard Medical School and neurology staff at Massachusetts General Hospital (MGH).

Simonian holds a bachelor’s degree in biology from Princeton University and medical degree from the University of Pennsylvania. She lives in Boston, Massachusetts, United States.

Nancy Simonian is the CEO at Syros Pharmaceuticals, based in United States, North America. With a background in Biotechnology, Nancy Simonian has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.